Bosh sahifaHKMPF • OTCMKTS
add
Hikma Pharmaceuticals Plc
Yopilish kursi
26,20 $
Yillik diapazon
22,33 $ - 28,92 $
Bozor kapitalizatsiyasi
4,23 mlrd GBP
Oʻrtacha hajm
488,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
LON
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 779,00 mln | 7,60% |
Joriy xarajat | 226,50 mln | 20,48% |
Sof foyda | 66,50 mln | 125,42% |
Sof foyda marjasi | 8,54 | 109,83% |
Har bir ulushga tushum | — | — |
EBITDA | 144,00 mln | -17,95% |
Amaldagi soliq stavkasi | 20,36% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 213,00 mln | -6,99% |
Jami aktivlari | 5,13 mlrd | 9,68% |
Jami passivlari | 2,81 mlrd | 13,80% |
Umumiy kapital | 2,32 mlrd | — |
Tarqatilgan aksiyalar | 220,43 mln | — |
Narxi/balansdagi bahosi | 2,50 | — |
Aktivlardan daromad | 5,02% | — |
Kapitaldan daromad | 7,10% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 66,50 mln | 125,42% |
Operatsiyalardan naqd pul | 183,00 mln | -5,18% |
Sarmoyadan naqd pul | -137,50 mln | -28,50% |
Moliyadan naqd pul | -68,00 mln | 43,10% |
Naqd pulning sof oʻzgarishi | -24,00 mln | 28,36% |
Boʻsh pul | 44,69 mln | -41,73% |
Haqida
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Tashkil etilgan
1978
Sayt
Xodimlar soni
9 500
